Venture capital and other private financings of private biopharma companies, including: Aivita, Alladapt, Alx Oncology, Aurora Science, Azafaros, Canbridge, Ikarovec, Inotrem, Kahr Medical, Kaipharm, Maat Pharma, Neotx, Novelty Nobility, Omass, Oncodna, Pentixapharm, Pinpoint, Sonoma, Spruce Biosciences, Valo, Volastra.